<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[CBN Prevention, Diagnosis, and Treatment of Disease]]></title><link>http://www.upmc-biosecurity.org/</link><description><![CDATA[Clinicians' Biosecurity Network Report archive for prevention, diagnosis, and treatment of disease.]]></description><copyright><![CDATA[Copyright 2010. University of Pittsburgh Medical Center. All rights reserved.]]></copyright><managingEditor><![CDATA[cbn_editor@upmc-biosecurity.org]]></managingEditor><webmaster><![CDATA[cbn_editor@upmc-biosecurity.org]]></webmaster><lastBuildDate>Thu, 10 Jun 2010 04:03:07 GMT</lastBuildDate><generator>SiteExecutive v4.1</generator><item><title><![CDATA[Seasonal Flu Vaccination May Offer Partial Immunity to H5N1 (02-21-2007)]]></title><link>http://www.upmc-cbn.org/report_archive/2007/02_February_2007/cbnreport_02212007.html</link><description><![CDATA[mice vaccinated with the N1  used in seasonal flu vaccine, had significantly reduced mortality when challenged with H5N1. Some people who have had seasonal influenza vaccination carry antibodies that react to the N1 in the avian H5N1 virus]]></description><guid isPermaLink="true">http://www.upmc-cbn.org/report_archive/2007/02_February_2007/cbnreport_02212007.html</guid><pubDate>Wed, 21 Feb 2007 19:58:37 GMT</pubDate></item><item><title><![CDATA[Influenza Update: Diagnostic Test, Drug Resistance, and Possible Drug Interaction (11-16-2006)]]></title><link>http://www.upmc-cbn.org/report_archive/2006/11_November_2006/cbnreport_111606.html</link><description><![CDATA[Researchers at the University of Colorado, the CDC, and InDevR, LLC have designed a gene chip assay that can identify and subtype Influenza A virus, distinguishing, for example, between H3N2 and H5N1 in less than 7 hours.]]></description><guid isPermaLink="true">http://www.upmc-cbn.org/report_archive/2006/11_November_2006/cbnreport_111606.html</guid><pubDate>Thu, 16 Nov 2006 14:54:00 GMT</pubDate></item><item><title><![CDATA[Smallpox Antiviral Effective in Animal Trials (10-23-2006)]]></title><link>http://www.upmc-cbn.org/report_archive/2006/10_October_2006/cbnreport_102306.html</link><description><![CDATA[On October 18, 2006, SIGA Technologies, Inc. announced that its antiviral drug candidate SIGA-246 demonstrated a high degree of protection against variola, the smallpox virus, in a primate trial conducted at the CDC.]]></description><guid isPermaLink="true">http://www.upmc-cbn.org/report_archive/2006/10_October_2006/cbnreport_102306.html</guid><pubDate>Mon, 23 Oct 2006 18:45:00 GMT</pubDate></item></channel></rss>
